Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments

An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-termina...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2000-06, Vol.397 (2-3), p.291-296
Hauptverfasser: Scarselli, M, Armogida, M, Chiacchio, S, DeMontis, M G, Colzi, A, Corsini, G U, Maggio, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 296
container_issue 2-3
container_start_page 291
container_title European journal of pharmacology
container_volume 397
creator Scarselli, M
Armogida, M
Chiacchio, S
DeMontis, M G
Colzi, A
Corsini, G U
Maggio, R
description An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins.
doi_str_mv 10.1016/S0014-2999(00)00272-7
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71173762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71173762</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-970002eafbabc9dd6113eac0368e494e66bf6fd3415ed4b774840075bea714823</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhH0A0VL4CSCfUHswrB3Hbo6It1QJicc5sp0NCkriYDtS--9pRelpVqNvRqMl5ILDNQeubt4BuGSiKIo5wAJAaMH0EZke7Ak5jfEbAPJC5CdkwmEpJRdqStZv6HwfU5PG1Pie-prWY-92t2lp5QfTNT3S-7mICxrQ4ZB8oHZDnWe4HgLGuI_tQM-o6SvqTLB-vWlZwrB1t0WHZB3MV4d9imfkuDZtxPO9zsjn48PH3TNbvT693N2u2MCFSKzQ29UCTW2NdUVVKc4zNA4ytURZSFTK1qquMslzrKTVWi4lgM4tGs3lUmQzcvXXOwT_M2JMZddEh21revRjLDXnOtNqB17uwdF2WJVDaDoTNuX_r7JfeUZseQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71173762</pqid></control><display><type>article</type><title>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Scarselli, M ; Armogida, M ; Chiacchio, S ; DeMontis, M G ; Colzi, A ; Corsini, G U ; Maggio, R</creator><creatorcontrib>Scarselli, M ; Armogida, M ; Chiacchio, S ; DeMontis, M G ; Colzi, A ; Corsini, G U ; Maggio, R</creatorcontrib><description>An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins.</description><identifier>ISSN: 0014-2999</identifier><identifier>DOI: 10.1016/S0014-2999(00)00272-7</identifier><identifier>PMID: 10844126</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Animals ; Apomorphine - pharmacology ; Binding, Competitive - drug effects ; Clozapine - pharmacology ; Colforsin - pharmacology ; COS Cells ; Cyclic AMP - metabolism ; Dopamine - pharmacology ; Dopamine Agonists - metabolism ; Dopamine Agonists - pharmacology ; Dopamine Antagonists - pharmacology ; Dose-Response Relationship, Drug ; Gene Expression ; Haloperidol - pharmacology ; Membranes - metabolism ; Peptide Fragments - drug effects ; Peptide Fragments - genetics ; Peptide Fragments - physiology ; Pergolide - pharmacology ; Quinpirole - pharmacology ; Radioligand Assay ; Rats ; Receptors, Dopamine D2 - drug effects ; Receptors, Dopamine D2 - genetics ; Receptors, Dopamine D2 - physiology ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - physiology ; Spiperone - analogs &amp; derivatives ; Spiperone - metabolism ; Spiperone - pharmacology ; Transfection ; Tritium</subject><ispartof>European journal of pharmacology, 2000-06, Vol.397 (2-3), p.291-296</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10844126$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scarselli, M</creatorcontrib><creatorcontrib>Armogida, M</creatorcontrib><creatorcontrib>Chiacchio, S</creatorcontrib><creatorcontrib>DeMontis, M G</creatorcontrib><creatorcontrib>Colzi, A</creatorcontrib><creatorcontrib>Corsini, G U</creatorcontrib><creatorcontrib>Maggio, R</creatorcontrib><title>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins.</description><subject>Animals</subject><subject>Apomorphine - pharmacology</subject><subject>Binding, Competitive - drug effects</subject><subject>Clozapine - pharmacology</subject><subject>Colforsin - pharmacology</subject><subject>COS Cells</subject><subject>Cyclic AMP - metabolism</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine Agonists - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gene Expression</subject><subject>Haloperidol - pharmacology</subject><subject>Membranes - metabolism</subject><subject>Peptide Fragments - drug effects</subject><subject>Peptide Fragments - genetics</subject><subject>Peptide Fragments - physiology</subject><subject>Pergolide - pharmacology</subject><subject>Quinpirole - pharmacology</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Receptors, Dopamine D2 - drug effects</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Receptors, Dopamine D2 - physiology</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - physiology</subject><subject>Spiperone - analogs &amp; derivatives</subject><subject>Spiperone - metabolism</subject><subject>Spiperone - pharmacology</subject><subject>Transfection</subject><subject>Tritium</subject><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtPwzAQhH0A0VL4CSCfUHswrB3Hbo6It1QJicc5sp0NCkriYDtS--9pRelpVqNvRqMl5ILDNQeubt4BuGSiKIo5wAJAaMH0EZke7Ak5jfEbAPJC5CdkwmEpJRdqStZv6HwfU5PG1Pie-prWY-92t2lp5QfTNT3S-7mICxrQ4ZB8oHZDnWe4HgLGuI_tQM-o6SvqTLB-vWlZwrB1t0WHZB3MV4d9imfkuDZtxPO9zsjn48PH3TNbvT693N2u2MCFSKzQ29UCTW2NdUVVKc4zNA4ytURZSFTK1qquMslzrKTVWi4lgM4tGs3lUmQzcvXXOwT_M2JMZddEh21revRjLDXnOtNqB17uwdF2WJVDaDoTNuX_r7JfeUZseQ</recordid><startdate>20000602</startdate><enddate>20000602</enddate><creator>Scarselli, M</creator><creator>Armogida, M</creator><creator>Chiacchio, S</creator><creator>DeMontis, M G</creator><creator>Colzi, A</creator><creator>Corsini, G U</creator><creator>Maggio, R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20000602</creationdate><title>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</title><author>Scarselli, M ; Armogida, M ; Chiacchio, S ; DeMontis, M G ; Colzi, A ; Corsini, G U ; Maggio, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-970002eafbabc9dd6113eac0368e494e66bf6fd3415ed4b774840075bea714823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Apomorphine - pharmacology</topic><topic>Binding, Competitive - drug effects</topic><topic>Clozapine - pharmacology</topic><topic>Colforsin - pharmacology</topic><topic>COS Cells</topic><topic>Cyclic AMP - metabolism</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine Agonists - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gene Expression</topic><topic>Haloperidol - pharmacology</topic><topic>Membranes - metabolism</topic><topic>Peptide Fragments - drug effects</topic><topic>Peptide Fragments - genetics</topic><topic>Peptide Fragments - physiology</topic><topic>Pergolide - pharmacology</topic><topic>Quinpirole - pharmacology</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Receptors, Dopamine D2 - drug effects</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Receptors, Dopamine D2 - physiology</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - physiology</topic><topic>Spiperone - analogs &amp; derivatives</topic><topic>Spiperone - metabolism</topic><topic>Spiperone - pharmacology</topic><topic>Transfection</topic><topic>Tritium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scarselli, M</creatorcontrib><creatorcontrib>Armogida, M</creatorcontrib><creatorcontrib>Chiacchio, S</creatorcontrib><creatorcontrib>DeMontis, M G</creatorcontrib><creatorcontrib>Colzi, A</creatorcontrib><creatorcontrib>Corsini, G U</creatorcontrib><creatorcontrib>Maggio, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scarselli, M</au><au>Armogida, M</au><au>Chiacchio, S</au><au>DeMontis, M G</au><au>Colzi, A</au><au>Corsini, G U</au><au>Maggio, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2000-06-02</date><risdate>2000</risdate><volume>397</volume><issue>2-3</issue><spage>291</spage><epage>296</epage><pages>291-296</pages><issn>0014-2999</issn><abstract>An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins.</abstract><cop>Netherlands</cop><pmid>10844126</pmid><doi>10.1016/S0014-2999(00)00272-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2000-06, Vol.397 (2-3), p.291-296
issn 0014-2999
language eng
recordid cdi_proquest_miscellaneous_71173762
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Apomorphine - pharmacology
Binding, Competitive - drug effects
Clozapine - pharmacology
Colforsin - pharmacology
COS Cells
Cyclic AMP - metabolism
Dopamine - pharmacology
Dopamine Agonists - metabolism
Dopamine Agonists - pharmacology
Dopamine Antagonists - pharmacology
Dose-Response Relationship, Drug
Gene Expression
Haloperidol - pharmacology
Membranes - metabolism
Peptide Fragments - drug effects
Peptide Fragments - genetics
Peptide Fragments - physiology
Pergolide - pharmacology
Quinpirole - pharmacology
Radioligand Assay
Rats
Receptors, Dopamine D2 - drug effects
Receptors, Dopamine D2 - genetics
Receptors, Dopamine D2 - physiology
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - physiology
Spiperone - analogs & derivatives
Spiperone - metabolism
Spiperone - pharmacology
Transfection
Tritium
title Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T13%3A42%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reconstitution%20of%20functional%20dopamine%20D(2s)%20receptor%20by%20co-expression%20of%20amino-%20and%20carboxyl-terminal%20receptor%20fragments&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Scarselli,%20M&rft.date=2000-06-02&rft.volume=397&rft.issue=2-3&rft.spage=291&rft.epage=296&rft.pages=291-296&rft.issn=0014-2999&rft_id=info:doi/10.1016/S0014-2999(00)00272-7&rft_dat=%3Cproquest_pubme%3E71173762%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71173762&rft_id=info:pmid/10844126&rfr_iscdi=true